Vesicle Trafficking Trio Wins Nobel

James Rothman, Randy Schekman, and Thomas Südhof share Nobel Prize in Medicine or Physiology.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

James Rothman, Randy Schekman, Thomas Südhof (left to right) NOBELPRIZE.ORG, H GOREN © HHMI, FISCH Randy Schekman returned from Germany last night only to be woken up after a few hours of sleep by his wife yelling, “This is it!” after she heard the phone ring. “I snapped to attention,” Schekman told The Scientist. “My heart started to race.” The voice on the other end told him he had won the Nobel Prize. Schekman, a professor at the University of California, Berkeley, and two others—James Rothman of Yale University and Thomas Südhof of Stanford University—share the Nobel in Physiology or Medicine this year for their discoveries in the fundamental mechanisms of trafficking cellular cargo.

Each has made major contributions to understanding the organization of how vesicle contents are discharged at the cell membrane. And each came to similar answers from different angles. Schekman focused on yeast genetics, while Rothman used biochemical methods in mammalian cells, and Südhof worked on synaptic vesicles in nerve terminals.

At 4:00 AM, EDT, this morning, Schekman called his best friend, Bill Wickner at Dartmouth College, to tell him the good news. Wickner told The Scientist he was not surprised to hear that Schekman and the others had won. “It's been clear” they would, said Wickner, who has had decades-long relationships with each of the winners. He even introduced Schekman to his wife.

“They're three very different people. Each is very intelligent, very purposeful and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies